You are here
S50 nanocapsules for transcutaneous DNA vaccination
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI060268-01
Agency Tracking Number: AI060268
Amount:
$146,661.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
GENESEGUES, INC.
3180 HIGHPOINT DR
CHASKA, MN
55318
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: GRETCHEN Unger
Phone: (952) 443-3798
Email: GMU@GENESEGUES.COM
Phone: (952) 443-3798
Email: GMU@GENESEGUES.COM
Business Contact
Name: ROBERT UNGER
Phone: (952) 443-3798
Email: RTU@GENESEGUES.COM
Phone: (952) 443-3798
Email: RTU@GENESEGUES.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The WHO estimates that 40 million individuals are infected with AIDS worldwide and that 16,000 new infections occur daily, lending continuing support for new approaches in vaccine technology. DNA vaccines offer th
* Information listed above is at the time of submission. *